Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.
2.

An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.

Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D.

Int J Obes Relat Metab Disord. 2002 Oct;26(10):1363-6.

PMID:
12355332
[PubMed - indexed for MEDLINE]
3.

An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.

Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL.

Int J Obes Relat Metab Disord. 2001 Mar;25(3):316-24.

PMID:
11319627
[PubMed - indexed for MEDLINE]
4.

Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.

Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.

Int J Obes Relat Metab Disord. 2002 May;26(5):593-604.

PMID:
12032741
[PubMed - indexed for MEDLINE]
5.

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J; RIO-North America Study Group.

JAMA. 2006 Feb 15;295(7):761-75. Erratum in: JAMA. 2006 Mar 15;295(11):1252.

PMID:
16478899
[PubMed - indexed for MEDLINE]
6.

Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.

Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.

Int J Obes (Lond). 2006 Oct;30(10):1545-56. Epub 2006 Mar 21.

PMID:
16552410
[PubMed - indexed for MEDLINE]
7.

Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study.

Sengupta K, Mishra AT, Rao MK, Sarma KV, Krishnaraju AV, Trimurtulu G.

Lipids Health Dis. 2012 Sep 20;11:122. doi: 10.1186/1476-511X-11-122.

PMID:
22995673
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.

Astrup A, Breum L, Toubro S, Hein P, Quaade F.

Int J Obes Relat Metab Disord. 1992 Apr;16(4):269-77.

PMID:
1318281
[PubMed - indexed for MEDLINE]
9.

Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.

Preuss HG, DiFerdinando D, Bagchi M, Bagchi D.

J Med. 2002;33(1-4):247-64. Review.

PMID:
12939122
[PubMed - indexed for MEDLINE]
10.

Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.

Belza A, Frandsen E, Kondrup J.

Int J Obes (Lond). 2007 Jan;31(1):121-30. Epub 2006 Apr 25.

PMID:
16652130
[PubMed - indexed for MEDLINE]
11.

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J.

Int J Obes (Lond). 2006 Feb;30(2):331-41.

PMID:
16158082
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.

Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C.

JAMA. 1998 Nov 11;280(18):1596-600.

PMID:
9820262
[PubMed - indexed for MEDLINE]
13.

Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.

Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J.

JAMA. 2005 Jun 15;293(23):2873-83. Erratum in: JAMA. 2005 Sep 28;294(12):1491.

PMID:
15956632
[PubMed - indexed for MEDLINE]
14.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
[PubMed - indexed for MEDLINE]
15.

One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

Finer N, James WP, Kopelman PG, Lean ME, Williams G.

Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13.

PMID:
10757623
[PubMed - indexed for MEDLINE]
16.

A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.

Grube B, Chong PW, Lau KZ, Orzechowski HD.

Obesity (Silver Spring). 2013 Jan;21(1):58-64. doi: 10.1002/oby.20244.

PMID:
23505169
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.

Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M; OBES-002 Study Group.

Int J Obes Relat Metab Disord. 2004 Nov;28(11):1399-410.

PMID:
15486569
[PubMed - indexed for MEDLINE]
18.

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

Diabetes Obes Metab. 2000 Apr;2(2):105-12.

PMID:
11220522
[PubMed - indexed for MEDLINE]
19.

Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.

Greenway FL, De Jonge L, Blanchard D, Frisard M, Smith SR.

Obes Res. 2004 Jul;12(7):1152-7.

PMID:
15292480
[PubMed - indexed for MEDLINE]
20.

Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.

Molnár D, Török K, Erhardt E, Jeges S.

Int J Obes Relat Metab Disord. 2000 Dec;24(12):1573-8.

PMID:
11126208
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk